Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
318 studies found for:    LEUPROLIDE
Show Display Options
Rank Status Study
1 Active, not recruiting Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma
Condition: Prostatic Neoplasms
Intervention: Drug: Leuprolide Mesylate
2 Completed
Has Results
A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
Condition: Puberty, Precocious
Interventions: Drug: Leuprolide acetate 11.25 mg;   Drug: Leuprolide acetate 30 mg
3 Completed
Has Results
Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: leuprolide acetate FluidCrystal® injection depot;   Drug: leuprolide acetate
4 Completed
Has Results
A Study of Leuprolide to Treat Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Leuprolide acetate - Formulation A;   Drug: Leuprolide acetate - Formulation B
5 Completed
Has Results
Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty
Conditions: Precocious;   Leuprolide Acetate;   Luteinizing Hormone (LH);   Gonadotrophin-releasing Hormone Agonist (GnRHa);   Tanner Staging;   Depot Formulation;   Suppression of LH;   Central Precocious Puberty (CPP);   Gonadotrophin-releasing Hormone (GnRH);   Lupron;   GnRH Analog;   Pediatrics Central Precocious Puberty
Intervention: Drug: Leuprolide Acetate 3 Month Depot
6 Not yet recruiting A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Drug: Leuprolide
7 Recruiting ARN-509 and Leuprolide in Intermediate and High-risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Leuprolide acetate;   Drug: ARN-509;   Procedure: Radical prostatectomy
8 Not yet recruiting A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers
Condition: Endometriosis
Interventions: Drug: Leuprolide Oral Tablet QD;   Drug: Leuprolide Oral Tablet BID;   Drug: Leuprolide Depot
9 Completed
Has Results
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Leuprolide acetate 22.5 mg depot, GP-Pharm SA
10 Not yet recruiting Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
Conditions: Hyperandrogenemia;   Obesity;   Polycystic Ovary Syndrome
Intervention: Drug: Leuprolide
11 Completed Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide
Condition: Prostate Cancer
Intervention: Drug: Degarelix acetate, Leuprolide acetate
12 Completed Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: ELIGARD 22.5mg
13 Completed
Has Results
Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer
Condition: Prostatic Neoplasm
Intervention: Drug: leuprolide (Lucrin/Lucrin-Tri-depot)
14 Not yet recruiting Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast Cancer
Condition: Premenopausal Breast Cancer
Intervention: Drug: Pembrolizumab/ Exemestane/ Leuprolide
15 Completed Melanoma Vaccine With Peptides and Leuprolide
Condition: Melanoma
Interventions: Drug: Leuprolide;   Biological: GP100: 209-217(210M) Peptide;   Biological: MAGE-3 Peptide
16 Recruiting Analysis of Body Mass Index in Central Precocious Puberty Patients Treated With Leuprolide Acetate
Condition: Precocious Puberty, Central
Intervention: Drug: Leuprolide
17 Completed
Has Results
Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"
Condition: Breast Cancer
Intervention: Drug: Leuprorelin Acetate
18 Completed
Has Results
Study of Lupron Depot In The Treatment of Central Precocious Puberty
Condition: Puberty, Precocious
Intervention: Drug: Lupron (leuprolide acetate)
19 Completed
Has Results
Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"
Condition: Breast Cancer
Intervention: Drug: Leuprorelin acetate
20 Recruiting Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate
Conditions: Prostatic Neoplasms;   Pelvic Nodal
Interventions: Drug: Enzalutamide;   Drug: Leuprolide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.